Application of baicalein extract in preparation of medicament for controlling hyperlipidemic fatty liver
A technology of hyperlipidemia and baicalein, which is applied in the direction of drug combination, pharmaceutical formula, plant raw materials, etc., to achieve the effects of reducing liver weight and liver coefficient, regulating blood lipids, and reducing content
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0039] Embodiment Pharmacodynamic experiment
[0040] 1. Test material
[0041] Experimental animals: SD rats, male, weighing 170-190 g, clean grade, provided by the Experimental Animal Center of Soochow University School of Medicine. Experimental animal production license number: XCYK (Su) 2002-0008, use license number: SYXK (Su) 2007-0035. During the experiment, the temperature of the feeding room was (20±2)°C.
[0042] Drugs and main reagents: baicalein extract: baicalein content ≥ 50%, brownish-yellow crystals, batch number: 090429, extracted from Scutellaria baicalensis root by the phytochemical laboratory of our institute, and stored in a refrigerator at 4°C. Lipingzhi (fenofibrate) capsules, produced by France Liboforni Pharmaceutical Co., Ltd., batch number: 93405, import drug registration certificate number: H20050004, prepared with 0.5% carboxymethylcellulose sodium solution (CMC-Na) before use into 1% drug concentration. Homemade lard; cholesterol, produced by S...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com